Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tectonic Therapeutic, Inc.

25.63
+2.129.02%
Post-market: 25.630.00000.00%17:59 EDT
Volume:140.33K
Turnover:3.51M
Market Cap:472.67M
PE:-7.07
High:25.75
Open:23.76
Low:23.76
Close:23.51
Loading ...

Company Profile

Company Name:
Tectonic Therapeutic, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
44
Office Location:
490 Arsenal Way,Suite 210,Watertown,Massachusetts,United States
Zip Code:
02472
Phone:
- -
Fax:
- -
Introduction:
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.

Directors

Name
Position
Bruce Booth
Chairman of the Board
Annalisa Jenkins
Director
Christopher Paige
Director
Gail Farfel
Director
Ian Clark
Director
Philip J. Vickers
Director
Phillip Donenberg
Director

Shareholders

Name
Position
Erik Ostrowski
President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer
Azadeh Golipour
Chief Technology Officer
Deanna Petersen
Chief Business Officer
Essra Ridha
Chief Medical Officer
Steven Avruch
Chief Legal Officer and Secretary